Clincosm LogoSign in Get a demo

gastroesophageal junction adenocarcinoma

Showing NaN - NaN of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Bemarituzumab, Nivolumab, mFOLFOX6)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Phoenix, Arizona
  • +119 more
Feb 1, 2023

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Gastric Adenocarcinoma Trial in Worldwide (Evorpacept (ALX148),

Recruiting
  • Gastric Cancer
  • +2 more
  • Evorpacept (ALX148)
  • +3 more
  • Anaheim, California
  • +54 more
Jan 23, 2023

Small Cell Lung Cancer, NSCLC, Squamous, NSCLC, Non-squamous Trial in Worldwide (ladiratuzumab vedotin)

Recruiting
  • Small Cell Lung Cancer
  • +8 more
  • Chandler, Arizona
  • +65 more
Dec 19, 2022

Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,

Recruiting
  • Clinical Stage II Esophageal Adenocarcinoma AJCC v8
  • +27 more
  • Anchorage, Alaska
  • +469 more
Aug 24, 2022

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Bemarituzumab, mFOLFOX6, Placebo)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Anchorage, Alaska
  • +140 more
Aug 11, 2022

Advanced Solid Tumor, NSCLC, Melanoma Trial in United States (AB308, Zimberelimab)

Recruiting
  • Advanced Solid Tumor
  • +9 more
  • Phoenix, Arizona
  • +20 more
May 2, 2022

Advanced Solid Tumor, Gastric Cancer, Pancreas Cancer Trial in Los Angeles (TORL-2-307-ADC)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Los Angeles, California
    UCLA - JCCC Clinical Research Unit
Feb 10, 2022

Advanced Solid Tumor, Gastric Cancer, Pancreas Cancer Trial in Los Angeles (TORL-2-307-MAB)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Los Angeles, California
    UCLA - JCCC Clinical Research Unit
Jan 24, 2022

Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Ramucirumab, Capecitabine,

Completed
Has Results
  • Metastatic Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Fayetteville, Arkansas
  • +134 more
Jul 29, 2021

Metastatic Cancer, Melanoma, Gastric Cancer Trial in United States (VE800, Nivolumab, Vancomycin Oral Capsule)

Active, not recruiting
  • Metastatic Cancer
  • +4 more
  • VE800
  • +2 more
  • Scottsdale, Arizona
  • +17 more
Jun 22, 2021

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Andecaliximab, Nivolumab)

Completed
Has Results
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Los Angeles, California
  • +33 more
Sep 17, 2020

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Ramucirumab)

Completed
Has Results
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Tucson, Arizona
  • +44 more
Jun 26, 2020

Locally Advanced Unresectable Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma, Metastatic

Withdrawn
  • Locally Advanced Unresectable Gastric Adenocarcinoma
  • +5 more
  • Liposomal Irinotecan
  • +3 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Mar 25, 2020